Lean people with HIV can still develop fatty liver disease
Alternative first-line HIV regimen limits excess weight gain
Top 5 stories on long-term health for people living with HIV from CROI 2026
GLP-1 agonists could be a global game-changer, but need to be accessible and affordable
Less weight gain with Dovato than Biktarvy
Treatment changes do not reduce weight in people with HIV
Most liver disease in people with HIV in low and middle-income countries is caused by metabolic disorders
Muscle loss combined with excess fat frequently seen in Italian men with HIV
Switching from TAF to TDF leads to weight loss
